1. Home
  2. SAIA vs BIO Comparison

SAIA vs BIO Comparison

Compare SAIA & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Saia Inc.

SAIA

Saia Inc.

HOLD

Current Price

$317.46

Market Cap

9.1B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$266.38

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAIA
BIO
Founded
1924
1952
Country
United States
United States
Employees
N/A
7450
Industry
Trucking Freight/Courier Services
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
7.1B
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
SAIA
BIO
Price
$317.46
$266.38
Analyst Decision
Buy
Strong Buy
Analyst Count
19
4
Target Price
$382.44
$358.50
AVG Volume (30 Days)
501.7K
237.8K
Earning Date
04-24-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
9.52
N/A
Revenue
$3,234,286,000.00
N/A
Revenue This Year
$6.33
$2.74
Revenue Next Year
$9.33
$3.05
P/E Ratio
$33.92
$9.72
Revenue Growth
0.79
N/A
52 Week Low
$248.37
$211.43
52 Week High
$430.11
$343.12

Technical Indicators

Market Signals
Indicator
SAIA
BIO
Relative Strength Index (RSI) 34.31 41.30
Support Level $283.68 $239.33
Resistance Level $321.90 $289.61
Average True Range (ATR) 18.83 7.68
MACD -7.74 0.48
Stochastic Oscillator 7.40 24.82

Price Performance

Historical Comparison
SAIA
BIO

About SAIA Saia Inc.

Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 200 facilities and a fleet of more than 6,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: